Table 2.
Metabolites that were significantly different in the preeclampsia group in the mid-trimester cohort.
| Fold change | p Value | FDR | |
|---|---|---|---|
| Lipid molecules | |||
| LysoPC C19:0 | 0.72 | 0.002 | 0.000 |
| LysoPC C22:1 | 0.53 | 0.010 | 0.000 |
| LysoPE C16:1 | 1.73 | 0.018 | 0.783 |
| LysoPE C17:0 | 1.30 | 0.013 | 0.783 |
| LysoPE C20:0 | 1.46 | 0.044 | 0.783 |
| OxPC C38:4 + 1O | 0.76 | 0.048 | 0.336 |
| OxPI C38:4 + 1O | 0.73 | 0.044 | 0.277 |
| PC C32:1 | 1.37 | 0.007 | 0.783 |
| PC C32:2 | 1.33 | 0.009 | 0.783 |
| PE C23:1e | 0.65 | 0.030 | 0.231 |
| PE C24:1e | 0.46 | 0.031 | 0.231 |
| PE C34:3e | 0.81 | 0.031 | 0.277 |
| PI C36:2 | 0.72 | 0.014 | 0.231 |
| PI C38:3 | 11.23 | 0.041 | 0.783 |
| SM C28:1 | 0.66 | 0.011 | 0.000 |
| SM C30:1 | 1.53 | 0.020 | 0.783 |
| SM C34:1 | 2.22 | 0.044 | 0.783 |
| Primary metabolites | |||
| 3-Phosphoglycerate | 1.37 | 0.037 | 0.783 |
| Glutamate | 1.29 | 0.041 | 0.783 |
| Lyxose | 0.74 | 0.024 | 0.231 |
| Palmitoleic acid | 1.50 | 0.046 | 0.844 |
| Propane-1,3-diol | 0.91 | 0.028 | 0.231 |
| Xanthine | 1.43 | 0.044 | 0.783 |
* Statistical significance is presented by p value and false discovery rate (FDR) against control.